	Nationwide Incidence, Treatment Pattern, and Prognosis of Primary CNS Lymphoma in Taiwan, 2012-2020: A Retrospective Cohort Study. Cancer Med Hsiao FY, Lin HY, Chen HM, Hsu WH, Ko BS. PMID: 41906256 [PubMed - indexed for MEDLINE]
	Efficacy and safety of ATRA plus arsenic trioxide versus ATRA plus chemotherapy in newly diagnosed acute promyelocytic leukemia: a grade-assessed systematic review and meta-analysis. BMC Cancer Ahmad H, Henna F, Khurram S, Khan A, Ahmed A, Ali MH, Hassan MA, Abbas M, Farooq D, Muhammad S, Basit AA, Ahmad A. PMID: 41906112 [PubMed - as supplied by publisher]
	Cross-platform deep learning enables automated cytomorphologic subtyping of acute leukemia from bone marrow smears. Virchows Arch Wang G, Chen W, Zhao H, Chen X, Wu M, Yu Q, Liu Q, Liu H, Song E, Xue M, Sun C, Chu Z, Hu Y. PMID: 41906037 [PubMed - as supplied by publisher]
	Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration. Br J Haematol Caserta S, Martino EA, Skafi M, Alvaro ME, Bruzzese A, Amodio N, Fiorillo M, Lucia E, Olivito V, Labanca C, Mendicino F, Vigna E, Morabito F, Gentile M. PMID: 41905770 [PubMed - as supplied by publisher]
	Phase I Trial of Venetoclax and BEAM followed by Autologous Stem Cell Transplant for High-Risk non-Hodgkin Lymphoma. Transplant Cell Ther Maakaron JE, Zhao Q, Balakrishna JP, Puto M, Penza S, Maddocks KJ, Efebera YA, Saad A, deLima M, Devine S, Jaglowski S, William BM. PMID: 41905702 [PubMed - as supplied by publisher]
	Leukemia Diagnosis 2.0: Revolutionizing advanced and Futuristic Point-of-Care Detection and Monitoring. Crit Rev Oncol Hematol Rizwan A, Shamshad A, Hasan MR, Naikoo UM, Naithani D, Narang J, Farooqi H. PMID: 41905569 [PubMed - as supplied by publisher]
	Malignant transformation in patients with monoclonal gammopathy of undetermined significance treated with teriparatide for osteoporosis: a bicenter retrospective study and analysis of the French national pharmacovigilance database. Arch Osteoporos Cassez R, Cortet B, Bouvard B, Theis D, Potey C, Manier S, Paccou J, Philippoteaux C. PMID: 41904726 [PubMed - indexed for MEDLINE]
	Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial. Nat Commun Zhang Y, Nie M, Cao Y, Li Z, Huang H, Li G, Sun X, Liu P, Gao Y, Fang X, Bai B, Cai J, Li L, Liu Y, Peng S, Huang H, Xia Y, Cai Q. PMID: 41904192 [PubMed - as supplied by publisher]
	Real-world patterns of maintenance therapy after allogeneic transplant in older adults with acute myeloid leukemia: A Medicare cohort study. J Geriatr Oncol Kennedy VE, Block A, Young C, Nimke D, Kardel P, Pednekar P. PMID: 41903430 [PubMed - as supplied by publisher]
	The diagnostic potential of nanobodies in acute myeloid leukemia. Mol Biol Rep Ojaroodi AF, Mahrooghi D, Dastbaz M, Zohri A, Seddighi N, Ahmadi M. PMID: 41903065 [PubMed - in process]
	Investigating autophagy and miRNAs as therapeutic targets in leukemia. Discov Oncol Jamal-Al-Khreisat M, MazinBasheer N, Malathi H, Shankhyan A, Panigrahi R, Arora V, Ruzieva M, Usmanov R, GhazanfarAhari S. PMID: 41902977 [PubMed - as supplied by publisher]
	Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing. Support Care Cancer de Albornoz SC, Haysom H, Mo A, Guglielmino J, Dunstan T, Rushford K, Ellison A, Saxby K, Andrew D, Jesurajah A, Banahene P, Hu E, Hoo LS, Petrie D, Wood EM, Higgins AM, McQuilten ZK. PMID: 41902976 [PubMed - indexed for MEDLINE]
	Reconsidering time from diagnosis to treatment in acute myeloid leukemia: from therapeutic urgency to biologically informed timing. Expert Rev Hematol Molica M, De Fazio L, Porretto F, Mulè A, Rossi M, Martino M, Alati C. PMID: 41902783 [PubMed - as supplied by publisher]
	Detection of Bovine Leukemia Virus in Bone Marrow of Patients with B-Cell Precursor Acute Lymphoblastic Leukemia: A Case-Control Study. Viruses Núñez-Gutiérrez K, Fuentes-Montoya J, Enciso L, Jaime J, Corredor-Figueroa A. PMID: 41902250 [PubMed - indexed for MEDLINE]
	Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel) Hetta HF, Salama A, Aljuaid TA, Mojmami YT, Alotibi RS, Alqabaly AM, Aldosari NA, Alshahri SA, Asiri WIA, Alamri RS, Alanazi FA, Alenazi MSA, Albuhayri MH, Ramadan YN, Sayad R. PMID: 41901313 [PubMed]
	Autophagy and Lipid Metabolism as a Therapeutic Target for Overcoming Drug Resistance in Acute Myeloid Leukemia. Life (Basel) Bolandi SM, Pakjoo M, Fernandez-Marrero B, Boskabadi AR, Sephavand EM, Khorashad JS, Ghavami S, Eiring AM. PMID: 41900947 [PubMed]
	Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities. Cancers (Basel) Caprino F, Valentino I, Bruzzese A, Ganino L, Mesuraca M, Citraro R, Gentile M, Gallo Cantafio ME, Amodio N. PMID: 41899586 [PubMed]
	Specific Lipidomic Shifts in Chronic Lymphocytic Leukemia at Diagnosis. Cancers (Basel) Wojnicka J, Kie, Mertowska P, Mertowski S, Grywalska E, Sosnowski P, Wielgosz A, Kozub-P, Sosnowska-Pasiarska B, Klatka M, Klatka J, B. PMID: 41899502 [PubMed]
	The Exosome Landscape in Acute Myeloid Leukemia: From Molecular Mechanisms to Translational Frontiers. Genes (Basel) Vargas-Castellanos E, Barbosa-Lopéz D, Figueroa-Emiliani J. PMID: 41898823 [PubMed - indexed for MEDLINE]
	Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor VÎ² Clonality Predict Treatment-Free Remission After Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring Study. Int J Mol Sci Jo T, Saburi Y, Masunari T, Noguchi K, Sakai T, Taguchi J, Ohtsuka E, Sezaki N, Kubota-Koketsu R, Kiguchi T. PMID: 41898572 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 166831

Page 1 of 8342



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy